Effects of urocortin-2 on cellular Ca2+ homeostasis in right heart failure induced by pulmonary artery hypertension

R. Adão (Porto, Portugal), S. Kraler (Graz, Austria), S. Holzer (Graz, Austria), A. Leite-Moreira (Porto, Portugal), S. Sedej (Graz, Austria), C. Brás-Silva (Porto, Portugal)

Source: International Congress 2018 – On the right path: understanding and improving the function of an overloaded right heart ventricle
Disease area: Pulmonary vascular diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Adão (Porto, Portugal), S. Kraler (Graz, Austria), S. Holzer (Graz, Austria), A. Leite-Moreira (Porto, Portugal), S. Sedej (Graz, Austria), C. Brás-Silva (Porto, Portugal). Effects of urocortin-2 on cellular Ca2+ homeostasis in right heart failure induced by pulmonary artery hypertension. 1634

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Adrenergic receptor blocker reverses cardiac metabolic remodeling and improves right ventricular function in experimental pulmonary hypertension
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011

Urocortin-2 improves right ventricular function and attenuates experimental pulmonary arterial hypertension
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018


Carvedilol partially reverses maladaptive remodeling and improves function of the right ventricle (RV) in experimentally-induced pulmonary arterial hypertension (PAH)
Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases
Year: 2009


Systemic hypoxia contributes to pulmonary hypertension in heart failure
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011

In a model of genetic pulmonary hypertension, VIP attenuates pulmonary vascular remodeling and right ventricular hypertrophy
Source: Annual Congress 2007 - Pathogenesis and novel therapeutic targets in pulmonary hypertension
Year: 2007



Effects of acute increases in right ventricular preload and afterload on pulmonary artery pulse pressure in a chronic thromboembolic hypertension model
Source: International Congress 2018 – Experimental research in pulmonary hypertension
Year: 2018

Effects of BMPR-II signal transduction in the pulmonary vascular remodeling of monocrotaline induced pulmonary hypertension in rats
Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension
Year: 2008

Hypoxia-induced right heart failure
Source: Lung Science Conference 2006 - Hypoxia in Lung Biology and Disease
Year: 2006



Combining bosentan and sildenafil improves mitochondrial capacity and restores right ventricular contractility in established pulmonary hypertension
Source: Annual Congress 2007 - Pathogenesis and novel therapeutic targets in pulmonary hypertension
Year: 2007


Association of renal dysfunction with cardiac output and right atrial pressure in pulmonary arterial hypertension
Source: Annual Congress 2011 - Physiology of human pulmonary hypertension
Year: 2011

Effect of sitaxentan on haemodynamics and right ventricular hypertrophy in monocrotaline-induced pulmonary arterial hypertension (PAH)
Source: Annual Congress 2008 - Pulmonary vascular biology
Year: 2008


Right heart failure in pulmonary hypertension
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014



Effects of erythropoietin on advanced pulmonary vascular remodelling
Source: Eur Respir J 2008; 31: 126-134
Year: 2008



Increased right ventricular cardiomyocyte stiffness in patients with pulmonary arterial hypertension
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology
Year: 2012

Zamicastat decreases cardiac arrhythmias in a rat model of pulmonary arterial hypertension
Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Year: 2020


Targeted proteomics of right heart adaptation to pulmonary arterial hypertension
Source: Eur Respir J, 57 (4) 2002428; 10.1183/13993003.02428-2020
Year: 2021



Lodenafil improves hemodynamics and right ventricular remodeling in monocrotaline-induced model of pulmonary arterial hypertension in rats
Source: Annual Congress 2010 - Experimental pulmonary hypertension
Year: 2010

Dehydroepiandrosterone reverses chronic hypoxia/reoxygenation-induced right ventricular dysfunction in rats
Source: Eur Respir J 2012; 40: 1420-1429
Year: 2012



The association between resting and mild-to-moderate exercise pulmonary artery pressure
Source: Eur Respir J 2012; 39: 313-318
Year: 2012